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Abstract
Human embryonic stem cells (hESCs) can be induced to differentiate into blood cells using either co-culture with stromal
cells or following human embryoid bodies (hEBs) formation. It is now well established that the HOXB4 homeoprotein
promotes the expansion of human adult hematopoietic stem cells (HSCs) but also myeloid and lymphoid progenitors.
However, the role of HOXB4 in the development of hematopoietic cells from hESCs and particularly in the generation of
hESC-derived NK-progenitor cells remains elusive. Based on the ability of HOXB4 to passively enter hematopoietic cells in
a system that comprises a co-culture with the MS-5/SP-HOXB4 stromal cells, we provide evidence that HOXB4 delivery
promotes the enrichment of hEB-derived precursors that could differentiate into fully mature and functional NK. These hEB-
derived NK cells enriched by HOXB4 were characterized according to their CMH class I receptor expression, their cytotoxic
arsenal, their expression of IFNc and CD107a after stimulation and their lytic activity. Furthermore our study provides new
insights into the gene expression profile of hEB-derived cells exposed to HOXB4 and shows the emergence of
CD34
+CD45RA
+ precursors from hEBs indicating the lymphoid specification of hESC-derived hematopoietic precursors.
Altogether, our results outline the effects of HOXB4 in combination with stromal cells in the development of NK cells from
hESCs and suggest the potential use of HOXB4 protein for NK-cell enrichment from pluripotent stem cells.
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Introduction
Human embryonic stem cells (hESCs) represent a powerful tool
to analyze the early stages of human hematopoiesis [1,2]. Most
reports on hematopoietic differentiation from hESCs have focused
on erythroid, megakarocytic and myeloid pathways [3–15],
whereas the emergence of lymphocytes, and particularly of
functional Natural Killer (NK) cells from hESCs has rarely been
addressed so far [16,17]. NK cells are cellular components of the
innate immune system and play critical roles in protection against
pathogens and cancer [18]. New therapeutic protocols aiming at
improving the treatment of leukemias and cancers may commonly
comprise the use of fully mature NK cells and thus require the
availability of sufficient amounts of such cells [3,14].
In the human hematopoietic system, NK cells are tradition-
ally defined by the lack of T, B and myeloid markers and the
expression of CD56 and functional receptors mediating a com-
plex of inhibitory and activating signals that regulate their
activity. Killer-Immunoglobulin-Like-Receptor (KIR) and
CD94/NKG2 (A, B and C) heterodimers are the two major
receptors of Major Histocompatibility Complex (MHC) class I
molecules implicated in the control of NK-cell activity.
Expression of these receptors is coordinated and controlled all
along the differentiation of NK cells and these characteristics
have been duplicated on NK cells generated in vitro from
hematopoietic progenitors. On the other hand, the rare works
dealing with the in vitro differentiation of NK cells from hESCs
had shown that only certain stromal cells were permissive to the
expression of MHC class I receptors by the differentiating NK
cells [16,17]. Recently work in mice has shown that after in vivo
transfer, mature NK cells from MHC class–I deficient mice
could be licensed to the MHC class I of the host [19].
Therefore, the establishment of new protocols to generate
functional NK cells from pluripotent stem cells with the
potential to target treat malignant cells is of major interest.
The HOXB4 homeoprotein is an important regulator of
hematopoietic stem cell (HSC) self-renewal and expansion [20–
26].
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enhances their hemato-myeloid potential and allows these cells
to acquire ‘‘adult-like’’ HSC characteristics [27–30]. Lentiviral-
based expression of HOXB4 in hESCs results in a growth
advantage in vitro but fails to improve engraftment [9,11].
Moreover, enforced expression of HOXB4 in hESCs increases
blood cell forming capacity in vitro and promotes HSCs
development into terminally differentiated myeloid cells
[11,31]. To date, one report demonstrated that recombinant
HOXB4 proteins such as tPTD-HOXB4 were able to promote
hematopoietic progenitor-cell formation from hESCs [13]. Since
homeoproteins behave as cell-penetrating molecules in a passive
and reversible internalizing process thus rendering genetic
manipulations dispensable [32], we developed a cell culture
system based on the active secretion of HOXB4 protein by an
engineered MS-5 mouse stromal cell line, the MS-5/SP-
HOXB4 cells (SP: signal peptide). These cells secrete bi-
ologically active HOXB4 protein and permit stimulation of
target cells by HOXB4. In this context, we previously
demonstrated the effects of HOXB4 on the expansion of
functional NK cells from human HSCs [26,33]. Utilizing this
system, we investigated in this work the effects of HOXB4 on
human embryoid body (hEB)-derived NK-cell progenitor
expansion and differentiation, and analyzed the expression of
the activating and inhibitory receptors as well as the cytotoxic
potential of the differentiated NK cells.
Methods
Cell Lines
hESCs from the H1 cell line (WiCell Research Institute,
USA) were cultured as described [34]. Cells were maintained on
a mitomycin C-inactivated mouse embryonic fibroblasts feeder
layer derived from ICR (CD-1) mice (Harlan Laboratories)
according to Inserm guidelines. Medium was changed daily and
consisted of complete DMEM/F12 1:1 (Invitrogen, Cergy
Pontoise, France) supplemented with 20% Knock Out serum
replacer (Invitrogen), and 10 ng/mL recombinant human basic
fibroblast growth factor (bFGF) (Invitrogen). The mouse stromal
cell lines MS-5 [35,36], MS-5/SP-HOXB4 (MS-5 transduced
with a lentiviral vector containing the mouse immunoglobulin
k-chain leader sequence for protein secretion upstream of the
human HOXB4 cDNA), as well as the MS-5/enhanced green
fluorescent protein (EGFP) cells (MS-5 transduced with a vector
containing the EGFP cDNA, referred to as control) (kindly
provided by Dr S. Fichelson, Cochin Institut, Paris, France)
[22,26,33], were grown in complete alpha-MEM containing
10% FCS (Abcys).
hEBs Formation
H1 colonies were harvested and cultured with IMDM
supplemented with 15% FCS (Abcys), 1 mM L-glutamine, 1%
penicillin/streptomycine, 0,1 mM b-mercaptoethanol (b-ME), 1%
non essential amino acids (all from Invitrogen) and 10 ng/mL
bFGF. The next day, medium was changed and replaced by the
same medium without bFGF and supplemented with a cocktail of
cytokines consisting in 100 ng/mL human Stem cell Factor
(hSCF), 100 ng/mL human Flt3-ligand (hFlt3), 10 ng/mL human
Interleukin-3 (hIL-3), 10 ng/mL human Interleukin-6 (hIl-6),
50 ng/mL human granulocyte colony stimulating factor (hG-
CSF), 10 ng/mL human Bone Morphogenetic Protein-4
(hBMP4), all from Abcys and 10 ng/mL human Vascular
Endothelial Growth Factor (hVEGF, Promocell, Belgium). The
culture medium was changed every 4–5 days until day 19 of hEBs
differentiation.
Primary Co-cultures
hEBs at day 19 were dissociated by collagenase IV and Cell
dissociation buffer enzyme-free (Invitrogen) treatment. As de-
scribed, hEB-derived total cells (15*10
3–50*10
3 cells/cm
2) were
co-cultured during 2 additional weeks with 30-Gy pre-irradiated
MS-5/SP-HOXB4 or MS-5/EGFP stromal cells in standard
complete H5100 human long-term culture medium (StemCell
Technologies, Grenoble, France) in T25 flasks (Fisher, Illkirch,
France) [26,33]. At the end of this period cells were counted,
analyzed by flow cytometry and cultured under NK cell
differentiation conditions.
Assessment of NK-cell Differentiation Potential
Cells derived from hEBs at day 19 and from primary co-cultures
with either MS-5/SP-HOXB4 or MS-5/EGFP cells were cultured
under NK-cell differentiation conditions (secondary co-culture). As
described, [26,33] total cells (2*10
3–10
4 cells/cm
2) were co-
cultured for three weeks with unmodified MS-5 cells, in RPMI
1640, complemented with 5% FCS (StemCell Technologies), 10%
human AB serum (Jack Boy, Toronto, Canada), 1 mM L-
glutamine, 1% penicillin/streptomycine, 0.1 mM b-ME and
human recombinant cytokines: 50 ng/mL hSCF, 50 ng/mL
hFlt3-Ligand, 5 ng/mL hIL-2, 20 ng/mL hIL-15 and 20 ng/
mL hIL-7 (Abcys). Half of the complete media was replaced
weekly.
Staining for Flow Cytometry
Phenotypic analyzis were performed on hEB-derived cells,
primary co-culture-derived cells and NK cells derived from
secondary co-culture cells. Cells were incubated for 30 minutes
at 4uC in phosphate buffered saline (PBS) containing 0.1% bovine
serum albumine (BSA) with the following monoclonal antibodies
(mAbs): CD16-fluorescein isothiocyanate (FITC) (clone 3G8),
CD13-phycoerythrin (PE) (clone SJ1D1), CD14-PE (clone
RMO52), CD33-PE (clone D3HL60.251), CD34-allophycocyanin
(APC) (clone 581), CD43-FITC (clone DFT1), CD45-PE (clone
J.33), CD56-PE/CD3-FITC (clone NKH-1/UCHT1), CD56-
APC (clone N.901), CD56- (clone N.901), CD158a,h- (clone
EB6.B), CD158b1/b2, j- (clone GL183), CD158e1/e2- (clone
Z27), CD158i- (clone FES172), CD159a- (clone Z199), CD335
(NKP46)- (clone Bab281) PE (all from Beckman Coulter,
Villepinte, France) and, CD14- (clone M5E2), CD15- (clone
HI98), CD16- (clone 3G8), CD33- (P67.6), CD64- (clone 10.1),
CD94- (clone HP-3D9), Perforin- (clone dG9), Granzyme A
(GzA)- (clone MOPC-21), GzB- (clone GB11), CD107a- (clone
H4A3) FITC, CD45 RA- (clone HI100) PE, CD161- (clone
DX12), IFNc- (clone B27)-APC, CD336 (NKP44)- (clone p44-
8.1), CD337 (NKP30)- (clone p30-15) alexafluor 647, CD56-PE/
Cyanin 7 (clone B159) (all from BD Biosciences, Le Pont de Claix,
France). To perform intracellular staining for HOXB4, cell
supernatants were removed from 48-h co-cultures of hEBs derived
total cells with MS-5/SP-HOXB4 and MS-5/EGFP and cells
were subsequently fixed and permeabilized with the Fix and
Perm
H kit (Invitrogen) according to the manufacturer’s instruc-
tions. The HOXB4 protein was detected using the I12 monoclonal
antibody against HOXB4 (gift from Dr A. Gould, MRC, London,
UK) and PE-conjugated secondary antibody to rat IgG2a (clone
2a 8F4, Beckman Coulter). To perform intracellular staining for
Perforin, Granzyme A, Granzyme B and IFNc, cells were fixed
and permeabilized with the Cytofix/Cytoperm
TM kit (BD
Pharmingen) according to the manufacturer’s instructions. Isotype
hESC-Derived NK-Cell Progenitors
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from BD Biosciences and Beckman Coulter. When cell surface
markers were investigated, dead cells were excluded using 7AAD
staining. Labelled cells were analyzed using a FACSCalibur flow
cytometer or a FACScantoII flow cytometer (Beckton Dickinson)
and analysed with CellQuest software, FacsDiva software or
FlowJo (Tristar).
NK-cell Stimulation (IL12/K562)
At the end of the NK permissive culture period, 20*10
3 cells
were seeded in 200 ml in 96-well round-bottomed microplates in
presence of IL-12 20 ng/mL or K562 cell line (ATCC, CCL-243)
[37] in a ratio of effector-target (E/T) 5 to 1 in the presence of
monensine (GolgiStop, BD Pharmingen) and the anti-CD107a-
FITC or the control isotype for 5 hours. CD107a is a marker of
intracytoplasmic cytolytic granules, which is translocated on the
cell surface as a result of effector cell degranulation. The
monensine prevents the acidification of the endosomal compart-
ment and the degradation of the FITC. Thereafter the 5 hours
culture, cells were labelled with the anti-CD56-PE mAb, fixed and
permeabilized with the Cytofix/Cytoperm kit (BD Pharmingen),
washed with Permwash (BD Pharmingen) and stained with the
anti-IFNc-APC or the control isotype. Cytotoxic cells are
considered as CD107a
+ cells expressing or not IFN-c staining.
Cytotoxicity Assay
We have used the Flow based killing assay (FLOKA) [38].
Briefly, the target human K562 cells were washed with PBS
resuspended at the concentration of 1*10
6 cells/mL, and then
labeled at 37uC for 10 minutes with 0.5 mM final concentration of
CarboxyFluorescein diacetate succinimidyl ester (CFSE, Molecu-
lar Probe). Labeling reaction was stopped with complete RPMI
media. Labeled target cells (2*10
4) were added to 96-well U
bottom culture plates along with indicated effector cells in
complete RPMI media. The E/T ratio was 10:1, 5:1 and 1:1.
After 5 hours, cells were washed resuspended in PBS and 7AAD
was added to each sample. The 7AAD staining is a marker for late
cells death and the percentage of 7AAD
+ cells in the CFSE
+ cell
gate corresponded to the cytotoxicity percentage. The spontane-
ous death of the target alone was inferior to 8%. The cytotoxic
assays were performed in triplicate.
RNA Extraction, Reverse Transcriptase and Real-time PCR
Total RNA was extracted from hEBs using RNeasy Mini kit
(Qiagen, Hilden, Germany) and one microgram of DNase-treated
RNA was transcribed into complementary DNA (cDNA) using
High Capacity cDNA RT Kit (Invitrogen, Groningen, Nether-
lands) according to the manufacturer’s instructions. The resulting
cDNA was analyzed for differential gene expression by using the
Real-time quantitative PCR (Q-PCR) as described previously [39]
on an Applied Biosystems 7900HT Fast Real-Time PCR System
(Invitrogen, Groningen, Netherlands). Briefly, Q-PCR was
performed in quadruplicate analysis of two RNA samples from
hEB-derived cells co-cultures with MS-5/SP-HOXB4 or MS-5/
EGFP using the Power SYBR Green PCR kt (Invitrogen,
Groningen, Netherlands) with 10 ng of cDNA and 300 nM of
primers in a final reaction volume of 20 mL according to the
manufacturer’s instructions (Invitrogen, Groningen, Netherlands).
Gene expression was calculated according to the formula: DCP
target (Ct control- CT sample)/DCP reference (Ct control - Ct
sample). This calculation was based on the expression ratio of
a target gene versus a reference gene, Hypoxanthine-guanine
phosphoribosyltransferase (HPRT) as the housekeeping gene for
normalizing the samples [40]. 2-DDCT designates the variation in
gene expression in hEB-derived cells co-cultured with MS-5/SP-
HOXB4 relative to control hEB-derived cells co-cultured with
MS-5/EGFP. Results are expressed as an x-fold increase or
decrease in gene expression in hEB-derived cells co-cultured with
MS-5/SP-HOXB4 compared to hEB-derived cells co-cultures
with MS-5/EGFP. Reverse and forward primer sequences are
shown in Table S1 [41,42].
Cell Expansion Analysis
The fold increase of NK cell numbers following MS-5/SP-
HOXB4 and MS-5/EGFP co-culture conditions result from the
absolute number of NK cells recovered per culture at the end of
the experiments divided by that measured at day 0 (that
correspond to NK cell numbers obtained from un-co-cultured
hEB cells at day 19). The relative expansion corresponds to the
fold increase of NK cell numbers following MS-5/SP-HOXB4
divided by the fold increase following MS-5/EGFP co-culture
conditions.
Statistical Analysis
Data are expressed as mean 6 SEM. Statistical significance was
assessed using the Student’s t test. Differences with p,0.05 were
considered statistically significant.
Results
MS-5 Feeders Promote the Generation of hEB-derived
CD34
+CD45RA
+ Progenitor Cells
To assess whether passive transfer of HOXB4 protein promotes
and expands hESC-derived NK-cell progenitors, we designed
a two-step culture procedure as described in Figure 1A: hEB cells
were first co-cultured with MS-5/SP-HOXB4 or MS-5/EGFP.
Then, output cells were cultured in conditions permissive for NK-
cell differentiation. We confirmed that delivery of HOXB4 in the
culture supernatant leads to HOXB4 accumulation in hEB-
derived cells (Figure 1B). The human genes regulated by
homeoproteins during hematopoiesis are mostly unknown. How-
ever our previous work based on human CD34
+ cells revealed that
HOXB4 induces notable variations in the expression of key
molecules involved in cell growth, differentiation, and trans-
formation [42]. Thus in aim at evaluating whether HOXB4 could
have a relevant effect on hEB-derived target cells and based on our
previous work and those of Deneault et al. and Oshima et al. [42–
44], we analyzed here whether HOXB4 could modulate some of
its target genes in hEB-derived cells. Thus we performed gene
expression profile of MS-5/SP-HOXB4 and MS-5/EGFP co-
culture-derived cells regards AML1/RUNX1, GATA2, SCL/TAL-1,
BRCA2, CASP8, EZH2, GNL3, HPB1, MYC, HDAC2, IGFBP2 and
YPEL5. After hEB-derived cells exposure to HOXB4, we found
that HPB1, GNL3, IGFBP2 and HDAC2 expressions were
significantly up-regulated whereas EZH2 and YPEL5 expressions
were significantly down-regulated (Figure S1). We did not find any
significant modulation of AML1/RUNX1, GATA2, SCL/TAL-1,
BRCA2, CASP8, IKZF and MYC expressions when MS-5/SP-
HOXB4 co-cultures were compared to MS-5/EGFP control co-
cultures. These observations underline that HOXB4 internaliza-
tion in hEB-derived cells could modulate the expression of some
genes that is known to be modified by HOXB4 as previously
reported [42–44].
We attempted to clarify the influence of HOXB4 regarding the
early hematopoietic differentiation potential of hEB-derived cells.
We focused on CD43 known as a good marker of very early
hematopoietic precursors derived from hESCs co-cultured with
hESC-Derived NK-Cell Progenitors
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specification of human CD34
+ hematopoietic progenitors [45–49].
Figure 2A illustrates the FACS analysis of one representative
experiment out of five independent culture experiments. We found
no significant differences using MS-5/SP-HOXB4, MS-5/EGFP
or un-co-cultured hEB-derived cells in the proportions of CD34
+
(26.3614.9%, 17.365.5%, or 2563.3%, mean 6 SEM),
CD34
+CD43
+ (13.467.8%, 8.561.9% or 1361.4%) and
CD34
+CD45
+ cells (21.769%, 19.267.9% or 11.964.3%).
However, although CD34
+CD45RA
+ cells were generated in
proportions that did not differ from both MS-5/SP-HOXB4 or
MS-5/EGFP co-cultures (16.565.4% or 8.363.5%), no
CD34
+CD45RA
+ cells could be detected from un-co-cultured
hEBs (referred as day-0) (0.260.1%, p,0.05) despite an identical
proportion of total CD34
+ cells (Figure 2A and Figure 2B). These
results indicate that co-culture of hEB-derived cells with MS-5
feeders with or without HOXB4 was indispensable for generation
of CD34
+CD45RA
+ lymphoid specified hematopoietic progenitor
cells [45–49]. CD34
2CD43
+ and CD34
2CD45
+ cells obtained
from MS-5/SP-HOXB4 and MS-5/EGFP co-cultures or from
un-co-cultured hEB cells expressed myeloid markers such as
CD13, CD14, CD15, CD64 or CD33 (Figure S2 and Figure S3).
Interestingly CD33 was found to be expressed on a large
proportion of CD34
2CD43
+ cells but on few CD34
2CD45
+
derived from MS-5/SP-HOXB4 and MS-5/EGFP co-cultures or
from un-co-cultured hEB cells (Figure S2 and Figure S3).
Furthermore delivery of HOXB4 in hEB-derived cells induces
a 3.561.7 relative increase of total CD34
+ cells (Figure 2C). This
result shows a trend to expansion of hEB-derived hematopoietic
precursors exposed to HOXB4.
MS-5/SP-HOXB4 Generates Greater Numbers of NK Cells
After 19 days of hEB-cell cultures or after MS-5/SP-HOXB4 or
MS-5/EGFP co-cultures of hEB-derived cells, very rare NK
(CD45
+CD56
+CD3
2CD19
2) cells could be detected whereas
a large proportion of CD45
+ cells, that corresponded to myeloid
cells, were recovered after MS-5/SP-HOXB4 or MS-5/EGFP co-
cultures (Figures S3, Figure S4A and Figure S4B). Unselected cells
derived from the primary co-cultures of hEB-derived hematopoi-
etic progenitor cells with MS-5/SP-HOXB4, MS-5/EGFP
stromal and from un-co-cultured cells (day-0 control) were then
plated on unmodified MS-5 cells in conditions known to promote
NK cell differentiation and maintained during three weeks.
Figure 1. NK-cell culture procedure of hESC-derived hematopoietic precursor cells. Schematic representation of the three steps of NK-cells
differentiation from hESCs. hEBs derived from the H1 hESC cell line were dissociated then co-cultured with MS-5/SP-HOXB4 cells or MS-5/EGFP cells as
control during 2 weeks. Then, the cells derived from the first step of co-culture were submitted to a second step of 3-week co-culture with
unmodified MS-5 cells, in permissive conditions for NK-cell differentiation in presence of SCF, IL-2 and IL-15. NK-cell culture differentiation was
conducted directly with un-co-cultured hEB-derived cells as control. (B) Analysis of the presence of the HOXB4 protein within hEB-derived cells co-
cultured with either MS-5/SP-HOXB4 (dark line) or MS-5/EGFP (dotted line) stromal cell lines. Data are from one experiment out of two. Gray
histogram corresponds to isotypic control. Abbreviations : cy, cytoplasmic.
doi:10.1371/journal.pone.0039514.g001
hESC-Derived NK-Cell Progenitors
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in term of proportion of NK cells, i.e. 66.2624.4% when cultured
on MS-5/SP-HOXB4 versus 40629.5% when cultured on MS-5/
EGFP, whereas un-co-cultured hEBs generated 362.3% NK cells
(Figure 3A). In our NK culture conditions, all
CD56
+CD3
2CD19
2 cells were CD45
+ and no CD56
+ cells could
ever be detected within the rare CD45
2 cell fractions indicating
that all CD56
+ cells that could be recovered from NK cultures
correspond to hematopoietic cells (Figure S4C). Non-NK cells that
could be identified among NK condition cultures corresponded to
a mixture of myeloid cells (CD45
+CD14
+/CD15
+/CD64
+) (Figure
S4C).
Taken together, these results show that co-culture of hEBs with
MS-5 feeders with or without HOXB4 was essential for further
generation of NK cells.
Moreover, in five independent experiments illustrated in
Figure 3B, we found that there was a 32.2622.3-fold mean
increase in total NK-cell numbers after MS-5/SP-HOXB4 co-
culture conditions whereas NK cells derived from co-cultures of
hEB cells with MS-5/EGFP were expanded by only 14.3614.5-
fold (p,0.05) (relative improvement in NK-cell numbers: 1.7 to
14.7). The high standard deviations are due to an important
degree of heterogeneity between the experiments inherent to the
manipulation of hESCs. These results show that hematopoietic
precursor-cells derived from co-cultures with MS-5/SP-HOXB4
generated greater numbers of NK cells than their counterparts
derived from co-cultures with MS-5/EGFP (Figure 3B).
Furthermore after 2-week co-culture of hEB-derived cells with
MS-5/SP-HOXB4 followed by a 3-week NK-cell differentiation
culture, the absolute expansion rate of total cells (i.e NK cells
and non-NK cells) was 0.760.3 with MS-5/SP-HOXB4
whereas the absolute expansion rate of total cells was 0.460.2
with MS-5/EGFP (Figure S5). These data suggest strongly that
HOXB4 regulates the survival and/or expansion of hematopoi-
etic precursors during cultures, since the number of cells
retrieved was 2.160.6 times higher in the presence than in the
absence of HOXB4. This result indicates that HOXB4 could
enhance the final growth of total cells (that is NK cells and
myeloid cells) at the end of the culture period in comparison to
MS-5/EGFP cultures.
Altogether, these results show that MS-5 is mandatory for
hESCs to express an NK potential, and the presence of soluble
Figure 2. Analysis of hematopoietic progenitor cells among hEB-derived cells. (A) Phenotypic analysis of hEB-derived cells. Cells derived
from un-co-cultured hEBs or from hEB cells co-cultured with MS-5/SP-HOXB4 and MS-5/EGFP, were analysed by FACS according to CD34, CD43, CD45
and CD45RA antigen expression (one representative experiment out of three). (B) Percentages of cells co-expressing CD34 and CD43, CD45 and
CD45RA among total nucleated cells collected at day 14 after EB cells co-cultured with MS-5/SP-HOXB4 or MS-5/EGFP or directly obtained from un-
co-cultured hEBs (n=3, *p,0.05). (C) Relative expansion of total CD34
+ cells. Total CD34
+ cells were derived from hEB-derived cells co-culture with
MS-5/SP-HOXB4 or MS-5/EGFP. Bar represents fold amplification relative to MS-5/EGFP control (designated as 100%) from three independent
experiments.
doi:10.1371/journal.pone.0039514.g002
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well as myeloid cells). Finally, HOXB4 combined to the presence
of the MS-5stromal cells line could increase the final growth of
hematopoietic precursors leading to the enrichment of NK cells, in
NK-cell differentiation conditions, without modifying the NK
differentiation potential of hEB cells.
NK Cells Derived from Co-cultures with MS-5/SP-HOXB4
Express Inhibitory and Activating Receptors
We next evaluated whether NK cells expanded by HOXB4
were endowed with functional NK properties. All NK cells
expressed the dimeric inhibitory NK receptor CD94/CD159a
(NKG2A) and CD159 (NKG2D) and a fraction of them expressed
the Fc gamma receptor CD16, the NK receptor CD161 and the
KIR proteins CD158 (CD158a, b1, b2, e1, e2, h, i, j). More than
70% of these NK differentiated cells expresses the NK cell
activating receptors (natural cytotoxicity receptors) such as CD335
(NKp46), CD336 (NKp44) and CD337 (NKp30) (Figure 4). These
results showed that hEB cells exposed to HOXB4 could
differentiate into NK cells expressing the whole panel of
maturation markers. Functionally, the majority of NK cells
expressed a complete cytotoxic arsenal, with perforin, Granzyme
A and Granzyme B (Figure 4). Furthermore, a fraction of NK cells
exposed to K562 cells, expressed surface CD107a and intracellular
IFN-c cytokine demonstrating a fully functional phenotype.
Moreover, stimulation by IL-12 also induced IFN-c expression
suggesting that hEB-derived NK cells were sensitive to this
cytokine (Figure 5A) [50]. Finally, NK differentiated from hEB
exposed to HOXB4 had a powerful cytotoxic activity against
K562 cells in a dose dependent manner (Figure 5B) since target
cells stained with CFSE are all the better killed (7AAD positive
cells) as the number of NK cells effectors is important.
Discussion
In this report, we explored the influence of the HOXB4
homeoprotein on the generation and expansion of hESC-derived
NK-cell progenitors. We previously established a model in which
the passive transduction of the HOXB4 homeoprotein into
hematopoietic cells led to ex vivo expansion of human HSCs and
myeloid and lymphoid progenitors in the absence of exogenously
added cytokines [22,26,33]. We provided evidence that HOXB4
could be internalized within hEB-derived cells (Figure 1B). We
show here that HOXB4 promotes the survival and/or expansion
of hematopoietic precursors able to differentiate in NK cells in
Figure 3. Analysis of NK differentiation potential and NK progenitor cell expansion mediated by HOXB4. (A) Percentages of NK cells
(CD56
+CD3
2CD19
2) among nucleated cells collected at the end of 5 weeks of co-culture. Cells derived from the 2 weeks primary co-cultures with MS-
5/SP-HOXB4 or MS-5/EGFP were then plated on unmodified MS-5 cells in conditions known to promote NK-cell differentiation and maintained during
three weeks. At the end of the culture period, cells were analyzed by FACS for the expression of CD56 and CD3/CD19 markers. Un-co-cultured hEB
cells were directly cultured under NK-cell differentiation conditions for 3 weeks (n=5, *p,0.05, **p,0.01). (B) Fold increase of total NK cells. NK cells
were derived from total cells isolated from the primary 2-week co-cultures of hEB-derived cells with either MS-5/SP-HOXB4 or MS-5/EGFP control and
then cultured under NK-cell differentiation condition for three weeks. NK cells were then numbered. Bars represent fold amplifications relative to day-
0 control (un-co-cultured hEBs) (designated as 100%) (n=5, *p,0,05).
doi:10.1371/journal.pone.0039514.g003
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1.7 to 14.7 times higher in the presence of HOXB4. Thus co-
culture of hEB-derived hematopoietic precursors with MS-5/SP-
HOXB4 stromal cells results in a substantial output of NK cells
without disturbing the intrinsic NK-cell differentiation potential of
hEB-derived cells (Figure 3 and Figure S5). Finally, HOXB4 could
enhance the output of hEB-derived hematopoietic precursors that
are able to efficiently differentiate in NK cells under permissive
culture conditions whereas MS-5 cells were required to reveal NK-
cell differentiation potential of hEB-derived cells (Figure 2).
Furthermore, regarding our experimental model, one may wonder
which culture step allows NK-cell enrichment by HOXB4. NK-
cell enrichment induces by HOXB4 could proceed from the
cumulative effects of the first co-culture step that shows a trend to
expansion for hEB-derived cells exposed to HOXB4 (Figure 2C)
and from the secondary NK-culture condition which gives
a growth advantage to hEB-derived cells (endowed with NK and
myeloid differentiation potentials) exposed to HOXB4 (Figure S5)
leading to a final substantial output of NK cells (Figure 3). These
results give new insights regards the expansion of hESC-derived
hematopoietic precursors by the HOXB4 homeoprotein and open
perspectives concerning the potential effects of HOXB4 on
hematopoietic differentiation from human induced pluripotent
stem cells (hiPSCs) as it was recently shown in the murine model
[51].
Activated NK cells could represent a potential tool for the
therapy of hematopoietic malignancies combined with allogenic
bone marrow transplantation [14,52,53]. The rare works dealing
with the in vitro differentiation of NK cells from hESCs had shown
that only certain stromal cells (S17 and AFT024) were permissive
to the expression of MHC class I receptors by the differentiating
NK cells [16,17]. Here we show that contact with MS-5 cells was
an absolute requirement to the expression of the intrinsic NK-cell
differentiation potential (Figure 3A and Figure S4C) whereas
HOXB4 appears to have a growth action (Figure 3B and Figure
S5). Furthermore using H9 hESCs and two-step co-cultures with
S17 and AFT024 stromal cells, Woll et al. generated functional NK
cells that displayed potent in vivo anti-tumor activity [16,17]. Here
we show that using co-cultures comprising MS-5 stromal cells,
HOXB4-expanded NK-cell progenitors generated from H1
hESC-derived EBs, could give rise to fully mature NK cells
(Figure 4). Interestingly, HOXB4-enriched functional NK cells
produce IFN-c after stimulation by K562 targets and exhibit
a powerful lytic activity against them (Figure 5) providing a new
strategy for generating pluripotent stem cell-derived NK cells for
potential therapeutic applications. However, in our hands, this
Figure 4. Expression of inhibitory and activating receptors and of the cytotoxic arsenal of NK cells derived from co-culture with MS-
5/SP-HOXB4. NK cells were obtained from NK progenitors derived from hEB cells co-cultured with MS-5/SP-HOXB4. Cells were FACS analyzed for
surface expression of CD56, CD16, CD94, the mix of CD158a, h, CD158b1/b2, j, CD158e1/e2 and CD158i (referred as CD158) and of CD159, CD335,
CD336 and CD337. For CD159, CD94, CD335, CD336 and CD337 expression, cells were gated on CD56
+ cells (not shown). NK cells obtained using the
HOXB4 co-culture model were also analyzed for the intra-cytoplasmic expression of Perforin, Granzyme-A and Granzyme-B. Cells were gated on
CD56
+ cells (not shown). Data are from one experiment out of two.
doi:10.1371/journal.pone.0039514.g004
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NK-cell progenitor expansion from adult hHSCs which could
allow the production of large amounts of NK cells as we showed
previously [26,33]. This might be due to hEB hematopoietic
precursors-derived cells that are intrinsically different from adult
hHSCs and respond less efficiently to HOXB4 than adult hHSCs
do. Furthermore, regarding our experimental model, one may also
wonder whether HOXB4-dependent expansion is due to the
homeoprotein activity in hEB-derived cells (direct effect) or to
other factors attributed to HOX-expressing MS-5 cells (indirect
effect). Several observations argue strongly against the latter
mechanism. First, MS-5/SP-HOXB4 cells induced enhanced
human cell expansion when compared with MS-5/HOXB4 (MS-
5 transduced with a lentiviral vector which does not contain the
mouse immunoglobulin k-chain leader sequence for protein
secretion upstream the human HOXB4 cDNA) indeed
CD34
+CD38
low cells were much less sensitive to the action of
non actively secreted HOXB4, thus providing an internal control
against an indirect effect of HOXB4 through MS-5 cell changes
[22]. Second, the phenotype characteristics (such as morphology
and growth rate) of MS-5 cells were not modified by any of the
transductions as already shown [22,26,33,42]. Third, MS-5 cells
engineered to secrete lower amounts of human HOXB4 revealed
a dose dependent effect on the response of hematopoietic
precursors [22]. This strongly argues for a direct role of the
secreted homeoproteins on human HSCs.
At the molecular level, the mechanisms of action of HOX genes
during hematopoiesis remain elusive. Although reports have
described the involvement of HOX genes in some molecular
pathways in mice [54,55], the HOX protein targets in human
hematopoietic cells are mostly unidentified especially if these cells
correspond to precursors derived from ESCs. However, we
Figure 5. Functional activity of NK cells derived from co-culture with MS-5/SP-HOXB4. (A) The functional activity of cells was assessed in
the presence of IL-12 and against K562 target cells; the NK-cell activity was evaluated by the mobilisation of the CD107a antigen on the cell surface
and the intra-cytoplasmic expression of IFNc. Cells were gated on CD56
+ cells (not shown). (B) Cytotoxic activity of NK effector cells against target
K562 cells. a) Target K562 cells were labelled by CFSE. b) Percentage of 7AAD
+ death cells among the CFSE
+ target cells at various Effector-Target (E/T)
ratios (one experiment out of two). c) Percentage of cytotoxicity (i.e percentage of 7AAD
+ death cells among the CFSE
+ target cells) according to the
ratio E/T (dotted line and bold line represent two independent experiments).
doi:10.1371/journal.pone.0039514.g005
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poietic and embryonic cell models, particularly, studies including
gene expression analysis of cells that over-expressed HOXB4 [42–
44]. Here, our observations outline that HOXB4 internalization in
hEB-derived cells could modulate the expression of some genes
that regulate stem cells and cancer cells, transcription, cell cycle
progression, developmental events or cell differentiation (Figure
S1) [42–44]. Gene expression variations reported in this study and
in various publications often lead to divergent or contradictory
results because the models used in the studies are different. Here,
our molecular analysis based on a model of human ESC-derived
hematopoietic precursors exposed to HOXB4, i) gives new insights
into the modulation of gene expression by HOXB4, ii) might add
a supplementary degree of complexity regarding potential
HOXB4 target gene expressions and iii) confirms that the
observed effect of HOXB4 on NK-cell production from hEB-
derived cells is relevant.
Finally, our study describes for the first time the emergence of
CD34
+CD45RA
+ cells from hESC-derived hEB cells co-cultured
with MS-5 stromal which could give new perspectives regards the
early steps of human lymphopoiesis from pluripotent stem cells.
Indeed, regarding the early steps of human hemato-lymphopoiesis,
J. Dick’s group recently provided a comprehensive analysis of the
human hematopoietic hierarchy and identified human multi-
lymphoid progenitors, as a distinct population of CD45RA
+ cells
in the CD34
+CD38
2 adult stem cell compartment, that give rise
to all lymphoid cell types, as well as monocytes, macrophages and
dendritic cells, which indicated that these myeloid lineages arise in
early lymphoid lineage specification marked by the early
acquisition of CD45RA [48,49]. Thus based on these new insights
regards human hematopoiesis and on our previous works regards
early human lymphopoiesis [46,47], CD45RA could be consid-
ered as a candidate marker for lymphoid specification of
pluripotent stem cells.
Overall, these results open a field on the characterization of
hESC- and iPSC-derived early lymphoid progenitors and provide
experimental tools to model genetic disorders of the lymphoid
system development from pluripotent stem cells. Finally, they
could be the basis for the future development of immunotherapy
strategies for cancer or leukemia.
Supporting Information
Figure S1 Gene expression modulations by HOXB4.
Gene expression changes for AML1/RUNX1 GATA2, SCL/TAL1,
BRCA2, CASP8, EZH2 GNL3, HBP1, HDAC2, IGFBP2, IKZF,
YPEL5, MYC transcripts were measured by quadruplicate analysis
of two RNA samples from human hEB-derived cells co-cultured
with MS-5/SP-HOXB4 or MS-5/EGFP. Relative differences in
gene expression were calculated by using the 2-ddCt method,
which involves normalizing the Ct value for each gene to the Ct
value of the HPRT housekeeping gene. Values are shown as the
fold induction in hEB-derived cells co-cultured with MS-5/SP-
HOXB4 (grey bars) compared to hEB-derived cells co-cultured
with MS-5/EGFP (black bars). Data represent mean 6 SEM, NS:
not significant, n=4, *p,0.05, **p,0.01.
(TIF)
Figure S2 Phenotypic analysis of CD34
2CD43
+ cells.
CD34
2CD43
+ cells derived from hEBs at day 19 of culture (day-
0 control condition) and hEB-derived cells co-culture with MS-5/
SP-HOXB4 or MS-5/EGFP stromal cells were FACS analyzed
for the cell surface expression of myeloid markers such as CD13,
CD14 and CD33. Data represent on experiment out of two.
(TIF)
Figure S3 Phenotypic analysis of CD34
2CD45
+ cells.
CD34
2CD45
+ cells derived from hEBs at day 19 of culture (day-
0 control condition) and hEB-derived cells co-culture with MS-5/
SP-HOXB4 or MS-5/EGFP stromal cells were FACS analyzed
for the cell surface expression of myeloid markers such as CD14,
CD15, CD33 and CD64. Data represent on experiment out of
two.
(TIF)
Figure S4 Phenotypic analysis of CD56
+ cells. CD56
+ cells
derived from hEBs at day 19 of culture (day-0 control condition)
and hEB-derived cells co-culture with MS-5/SP-HOXB4 or MS-
5/EGFP stromal cells were FACS analyzed for the cell surface
expression of CD45 and CD14/15/64. Data represent on
experiment out of four.
(TIF)
Figure S5 Fold increase of total cells in NK condition.
Total cells (NK cells and non-NK cells) were derived from the
primary 2-week co-cultures of hEB-derived cells with either MS-
5/SP-HOXB4 or MS-5/EGFP control and then cultured under
NK-cell differentiation condition for three weeks. Total cells were
then numbered. Bar represents fold amplification relative to day-
0 control (un-co-cultured hEBs) (designated as 100%) (n=5,
*p,0,05).
(TIF)
Table S1 Primer sequences and access numbers
(DOCX)
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